Buscar
18/12/2025
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party
Tomaszewska, A, Basak, GW, Peczynski, C, Polge, E, Ambron, P, Boreland, W, Sica, S, Arat, M, Passweg, J, Lorenzo, JLL, Salmenniemi, U, Jindra, P, Kulagin, A, Bufarull, RM, Eder, M, Bekadja, MA, Mussetti, A, Graham, CE, Schoemans, H, Penack, O, Moiseev, I, Peric, Z. Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party. Cancers. 2025; 17(24)DOI:10.3390/cancers17244029. PMID:41463278. IF:4.400(Q2/3D).
18/12/2025
Hydrogen-Rich Water Potentiates Cannabinoid- and Gabapentinoid-Induced Analgesia in Neuropathic Pain
Tort, NA, Negrini-Ferrari, SE, Pol, O. Hydrogen-Rich Water Potentiates Cannabinoid- and Gabapentinoid-Induced Analgesia in Neuropathic Pain. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(24)DOI:10.3390/ijms262412155. PMID:41465581. IF:4.900(Q1/3D).
17/12/2025
Impact of arterial occlusion location on early neurological deterioration in patients with minor stroke treated with intravenous thrombolysis. The MINORCAT-END study
Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda-Gomez, C, Boned, S, Aragonès, JM, Silva, Y, Martínez, M, Doncel-Moriano, A, Ustrell, X, Camps-Renom, P, Mauri-Capdevila, G, Purroy, F, Rodríguez-Campello, A, Palomeras, E, Krupinski, J, Figueras-Aguirre, G, Catena, E, García-Alhama, J, Esteve-Belloch, P, Matos, N, Colom, C, Aguilo, O, Coll, A, Díaz, G, Tio, E, Ortega, O, Alfonso, S, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, de la Ossa, NP, Abilleira, S, Gomez-Choco, M. Impact of arterial occlusion location on early neurological deterioration in patients with minor stroke treated with intravenous thrombolysis. The MINORCAT-END study. NEUROLOGICAL SCIENCES. 2025; 47(1)DOI:10.1007/s10072-025-08721-7. PMID:41405770. IF:2.400(Q3/6D).
16/12/2025
Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration
Timiryasova, A, Greenberg, L, Domingo, P, Tarr, PE, Egle, A, Martin, C, Mussini, C, Wit, F, Cingolani, A, Lehmann, C, Castagna, A, Petoumenos, K, Sabin, CA, Bonnet, F, Lundgren, J, Bottanelli, M, Hosein, S, Carlander, C, Amstutz, A, Grabmeier-Pfistershammer, K, Garges, H, Marongiu, A, Young, LA, Peters, L, Ryom, L. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Cancers. 2025; 17(24)DOI:10.3390/cancers17244000. PMID:41463249. IF:4.400(Q2/3D).
16/12/2025
Patient safety risk associated with synchronous telehealth: A scoping review
de Oliveira, JSR, Fernandez, RS, Molina, MR, Pinto, ACPN, Rocha, CR, Ferreira, TM, Peres, SV. Patient safety risk associated with synchronous telehealth: A scoping review. PLoS One. 2025; 20(12)DOI:10.1371/journal.pone.0336992. PMID:41401191. IF:2.600(Q2/4D).
16/12/2025
Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score
Ranzani, OT, Singer, M, Salluh, JIF, Shankar-Hari, M, Pilcher, D, Berger-Estilita, J, Coopersmith, CM, Juffermans, NP, Laffey, J, Reinikainen, M, Neto, AS, Tavares, M, Timsit, JF, Lopez, MDA, Arulkumaran, N, Aryal, D, Azoulay, E, Celi, LA, Chaudhuri, D, De Lange, D, De Waele, J, Dos Santos, CC, Du, B, Einav, S, Engelbrecht, T, Fazla, F, Ferrer, R, Finazzi, S, Fujii, T, Gershengorn, HB, Greene, JD, Haniffa, R, Hao, SC, Hasan, MS, Hollenberg, S, Ippolito, M, Jung, C, Kirov, M, Kobari, S, Lakbar, I, Lipman, J, Liu, V, Liu, XL, Lobo, SM, Magatti, D, Martin, GS, Metnitz, B, Metnitz, P, Myatra, SN, Oczkowski, S, Paiva, JA, Paruk, F, Pekkarinen, PT, Piquilloud, L, Pölkki, A, Prescott, HC, Blaser, AR, Rezende, E, Robba, C, Rochwerg, B, Ruckly, S, Samei, R, Schenck, EJ, Secombe, P, Sendagire, C, Siaw-Frimpong, M, Simpkin, AJ, Soares, M, Summers, C, Szczeklik, W, Takala, J, Tanaka, S, Tricella, G, Vincent, JL, Wendon, J, Zampieri, FG, Rhodes, A, Moreno, R. Development and Validation of the Sequential Organ Failure Assessment (SOFA)-2 Score. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 334(23)DOI:10.1001/jama.2025.20516. PMID:41159833. IF:55.000(Q1/1D).
15/12/2025
Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations
Ferreira, JJ, Stocchi, F, Antonini, A, Rascol, O, Ebersbach, G, Kulisevsky, J, Fonseca, MM, Ramos, D, Rocha, JF, Brigas, HC, Holenz, J, Poewe, W. Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1715748. PMID:41473225. IF:2.800(Q2/5D).
15/12/2025
Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia
Arguello-Tomas, M, Lynton-Pons, E, Albiol, N, Lopez-Ferrer, A, Sierra, J, Moga, E, Moreno, C. Clinical and immunologic characteristics of nonhematologic autoimmune disorders in chronic lymphocytic leukemia. CANCER. 2025; 131(24)DOI:10.1002/cncr.70216. PMID:41378669. IF:5.100(Q1/3D).